1.
Type 2 diabetes
by Chatterjee, Sudesna, MD
The Lancet (British edition), 2017, Vol.389 (10085), p.2239-2251
2.
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
by Kautzky-Willer, Alexandra
Endocrine reviews, 2016-06, Vol.37 (3), p.278-316
3.
Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications
by Domingueti, Caroline Pereira
Journal of diabetes and its complications, 2015, Vol.30 (4), p.738-745
4.
Periodontitis and diabetes: a two-way relationship
by Preshaw, P. M
Diabetologia, 2011-11-06, Vol.55 (1), p.21-31
5.
Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial
by Gæde, Peter
Diabetologia, 2016-08-16, Vol.59 (11), p.2298-2307
6.
Type 2 diabetes across generations: from pathophysiology to prevention and management
by Nolan, Christopher J, Assoc Prof
The Lancet (British edition), 2011, Vol.378 (9786), p.169-181
7.
8.
The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities
by Brunkwall, Louise
Diabetologia, 2017-04-22, Vol.60 (6), p.943-951
9.
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
by Sun, Lulu
Nature medicine, 2018-12, Vol.24 (12), p.1919-1929
10.
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
by Bellamy, Leanne, MBBS
The Lancet (British edition), 2009, Vol.373 (9677), p.1773-1779
11.
Microbiota and diabetes: an evolving relationship
by Tilg, Herbert
Gut, 2014-09, Vol.63 (9), p.1513-1521
12.
Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline
by Peters, Anne L
The journal of clinical endocrinology and metabolism, 2016-11, Vol.101 (11), p.3922-3937
13.
Lower circulating irisin is associated with type 2 diabetes mellitus
by Liu, Jian-Jun
Journal of diabetes and its complications, 2013, Vol.27 (4), p.365-369
14.
Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice
by Zhang, Jie
Nature medicine, 2009-08, Vol.15 (8), p.940-945
15.
Diabetes in the older patient: heterogeneity requires individualisation of therapeutic strategies
by Schernthaner, Guntram
Diabetologia, 2018-02-07, Vol.61 (7), p.1503-1516
16.
Associations of objectively measured sedentary behaviour and physical activity with markers of cardiometabolic health
by Henson, J
Diabetologia, 2013-03-01, Vol.56 (5), p.1012-1020
17.
Diabetes in Asia
by Ramachandran, Ambady, Dr
The Lancet (British edition), 2010, Vol.375 (9712), p.408-418
18.
Mechanisms linking obesity to insulin resistance and type 2 diabetes
by Utzschneider, Kristina M
Nature, 2006-12-14, Vol.444 (7121), p.840-846
19.
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
by Ray, Kausik K, Dr
The Lancet (British edition), 2009, Vol.373 (9677), p.1765-1772
20.
Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus
by Broekhuizen, L. N
Diabetologia, 2010, Vol.53 (12), p.2646-2655
